Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epidemiology
100%
Diagnostic Performance
100%
Diagnostic Interventions
100%
Tuberculous Meningitis
100%
Global Situation
100%
Cerebrospinal Fluid
44%
Mycobacterium Tuberculosis (M. tb)
22%
Treatment Regimen
22%
Neuroimaging
11%
Risk Factors
11%
Ischemia
11%
Diagnostic Test
11%
Vaccination
11%
Drug Action
11%
Brain Injury
11%
Health Systems
11%
Clinical Signs
11%
High Dose
11%
Hydrocephalus
11%
Young children
11%
Linezolid
11%
Corticosteroids
11%
Clinical Symptoms
11%
Global Burden
11%
World Health Organization
11%
Tuberculosis Treatment
11%
Young Age
11%
Human Immunodeficiency Virus Infection
11%
Human Immunodeficiency Virus Negative
11%
Enhanced Sensitivity
11%
Turnaround Time
11%
Fluoroquinolones
11%
Start of Treatment
11%
Treatment Course
11%
Treatment Drugs
11%
Pulmonary Tuberculosis
11%
Drug Dosage
11%
Meninges
11%
Bacillus Calmette
11%
Meningitis Diagnosis
11%
Fluid Parameters
11%
Rifampicin
11%
Fluid Penetration
11%
Host-directed Therapy
11%
Acid-fast Bacilli
11%
GeneXpert
11%
Xpert Ultra
11%
Fluid Mode
11%
Cascade of Care
11%
Increased Intracranial Pressure
11%
Neurodisability
11%
Medicine and Dentistry
Cohort Effect
100%
Tuberculous Meningitis
100%
Cerebrospinal Fluid
33%
Quinolone Derivative
11%
Ischemia
11%
Human Immunodeficiency Virus Infection
11%
Base
11%
Health System
11%
Human Immunodeficiency Virus
11%
Drug Megadose
11%
Brain Injury
11%
Hydrocephalus
11%
Tuberculosis Treatment
11%
Linezolid
11%
Lung Tuberculosis
11%
Drug Action
11%
Meninx
11%
Rifampicin
11%
Cerebrospinal Fluid Penetration
11%
Acid Fast Bacterium
11%
Intracranial Pressure
11%
Diagnostic Test
11%
Clinical Symptom
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tuberculous Meningitis
100%
HIV
11%
Physical Disease by Body Function
11%
Ischemia
11%
Brain Injury
11%
Human Immunodeficiency Virus Infection
11%
Linezolid
11%
Lung Tuberculosis
11%
Quinolone Derivative
11%
Rifampicin
11%
Acid Fast Bacterium
11%
Base
11%
Hydrocephalus
11%
Drug Action
11%